EMA Withdrawn: Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals (split influenza virus, inactivated, containing antigen: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14)) — GlaxoSmithKline Biologicals S.A.

View source ↗

Summary

The EMA withdrew Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) by GlaxoSmithKline Biologicals, a pre-pandemic H5N1 vaccine develo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disease Outbreaks

Drugs mentioned

• Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted)

Snippet

Status: Withdrawn. Therapeutic area: Influenza, Human;Immunization;Disease Outbreaks. MAH: GlaxoSmithKline Biologicals S.A.. Decision date: 03/10/2011